Bid Publish Date
01-Jan-2025, 1:55 pm
Bid End Date
22-Jan-2025, 2:00 pm
EMD
₹4,200
Location
Progress
Quantity
322950
Public procurement opportunity for Indian Army CILOSTAZOL 100 MG TAB, ACENOCOUMAROL ACITROM 2 MG TAB, DILTIAZEM 90 MG SR TAB, MOXONIDINE 0 point 2 MG TAB, LEVOCARNITINE 1 GM INJECTION, ETIZOLAM 0 point 5 MG TAB, CLOZAPINE 25 MG TAB, TADALAFIL 10 MG TAB, EXEMESTANE 25 MG TAB, CLOTRIMAZOLE 100 MG VAGINAL TABLETS, POVIDONE IODINE 200 MG PESSARY, CINNARIZINE 25 MG TAB STUGERON, DABIGATRAN 75 MG TAB, CILNIDIPINE 5 MG TAB, GLUCOSAMINE 250 MG plus CHONDROITIN SULPHATE 200 MG CAP, LEFLUNOMIDE ARAVA 20 MG TAB, ACENOCOUMAROL 1 MG TAB Acitrome, DULOXETINE 20 MG CAP, ESCITALOPRAM 10 MG TAB, ESCITALOPRAM 20 MG TAB, MOXONIDINE 0 point 3 MG TAB, OXCARBAZEPINE 150 MG TAB, OXYBUTYNIN 2 point 5 MG TAB, PRAMIPEXOLE 0 point 25 MG TAB, LEVOSULPIRIDE 75 MG plus ESOMEPRAZOLE 40 MG CAP, ROPINIROLE 1MG TAB, TAMSULIN 0 point 4 MG plus DUTASTERIDE 5 MG TAB URIMAX D TAB, VENLAFAXINE 75 MG TAB, TEMOZOLOMIDE 20 MG TAB, TRIMETAZIDINE MR 35 MG TAB, PAROXETINE 12 point 5 MG TAB, PYRIDOXIN 100 MG TAB, PYRIDOXIN 40 MG TAB, FAROPENEM SODIUM 200 MG TAB, FLUVOXAMINE LUVOX 100 MG TAB, NOVELON TAB ETHINYL ESTRADIOL 0 point 03MG plus DESOGESTREL 0 point 15 MG, AMANTADINE 100 MG TAB, GABAPENTIN 300 MG TAB CAP, LETROZOLE 2 point 5 MG TAB, MEDROXY PROGESTRONE 10 MG TAB, CARBIMAZOLE 20 MG TAB, PHENYTOIN SODIUM 100 MG, PIOGLITAZONE 15 MG TAB, SILDENAFIL CITRATE 50 MG TAB, DIGOXIN 0 point 25 MG TAB, MELATONIN 3 MG TAB, TRIHEXYPHENIDYL 2 MG TAB PACITANE, CYPROTERONE 2 MG plus ETHINYL ESTRADIOL 0 point 035 MG DIANE 35 TAB, IMIPRAMINE 25 MG TAB, HYDROXYUREA 500 MG CAP, CYCLOSPORIN 100 MG TAB, CLOBAZAM 5 MG TAB, PROPRANOLOL 20 MG TAB, ACEBROPHYLLINE 100 MG TAB, FLUOXETINE 20MG TAB, MODAFI0 100 MG TAB, DARIFENACIN 7 point 5 MG TAB, LAMOTRIGINE 25 MG TAB, CLONAZEPAM 0 point 25 MG TAB, QUETIAPINE 25 MG TAB, IBANDRONIC ACID 150 MG TAB, CLOFAZIMINE 100 MG CAP, CLOMIPRAMINE 25 MG TAB, DANAZOL 100 MG TAB, TACROLIMUS 1 MG TAB, DIVALPROEX 500 MG TAB, CHLORTHALIDONE 12 point 5 MG TAB, DIVALPROEX 250 MG TAB, OXCARBAZEPINE 300 MG TAB, METHYLPREDNISOLONE 4 MG TAB, PIRACETAM 400 MG TAB, BUPROPION 150 MG TAB, ESOMEPRAZOLE 40 MG TAB, EPLERENONE 25 MG TAB, ETORICOXCIB 120 MG TAB, FLUNARIZINE 10 MG TAB, RISPERIDONE 1 MG TAB, PROCHLOROPERAZINE 5 MG TAB, PENTOXIFYLLINE 400 MG TAB, SACUBITRIL 97 MG plus VALSARTAN 103 MG TAB in JABALPUR, MADHYA PRADESH. Quantity: 322950 issued by. Submission Deadline: 22-01-2025 14: 00: 00. View full details and respond.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
CILOSTAZOL 100 MG TAB , ACENOCOUMAROL ACITROM 2 MG TAB , DILTIAZEM 90 MG SR TAB , MOXONIDINE 0 point 2 MG TAB , LEVOCARNITINE 1 GM INJECTION , ETIZOLAM 0 point 5 MG TAB , CLOZAPINE 25 MG TAB , TADALAFIL 10 MG TAB , EXEMESTANE 25 MG TAB , CLOTRIMAZOLE 100 MG VAGINAL TABLETS , POVIDONE IODINE 200 MG PESSARY , CINNARIZINE 25 MG TAB STUGERON , DABIGATRAN 75 MG TAB , CILNIDIPINE 5 MG TAB , GLUCOSAMINE 250 MG plus CHONDROITIN SULPHATE 200 MG CAP , LEFLUNOMIDE ARAVA 20 MG TAB , ACENOCOUMAROL 1 MG TAB Acitrome , DULOXETINE 20 MG CAP , ESCITALOPRAM 10 MG TAB , ESCITALOPRAM 20 MG TAB , MOXONIDINE 0 point 3 MG TAB , OXCARBAZEPINE 150 MG TAB , OXYBUTYNIN 2 point 5 MG TAB , PRAMIPEXOLE 0 point 25 MG TAB , LEVOSULPIRIDE 75 MG plus ESOMEPRAZOLE 40 MG CAP , ROPINIROLE 1MG TAB , TAMSULIN 0 point 4 MG plus DUTASTERIDE 5 MG TAB URIMAX D TAB , VENLAFAXINE 75 MG TAB , TEMOZOLOMIDE 20 MG TAB , TRIMETAZIDINE MR 35 MG TAB , PAROXETINE 12 point 5 MG TAB , PYRIDOXIN 100 MG TAB , PYRIDOXIN 40 MG TAB , FAROPENEM SODIUM 200 MG TAB , FLUVOXAMINE LUVOX 100 MG TAB , NOVELON TAB ETHINYL ESTRADIOL 0 point 03MG plus DESOGESTREL 0 point 15 MG , AMANTADINE 100 MG TAB , GABAPENTIN 300 MG TAB CAP , LETROZOLE 2 point 5 MG TAB , MEDROXY PROGESTRONE 10 MG TAB , CARBIMAZOLE 20 MG TAB , PHENYTOIN SODIUM 100 MG , PIOGLITAZONE 15 MG TAB , SILDENAFIL CITRATE 50 MG TAB , DIGOXIN 0 point 25 MG TAB , MELATONIN 3 MG TAB , TRIHEXYPHENIDYL 2 MG TAB PACITANE , CYPROTERONE 2 MG plus ETHINYL ESTRADIOL 0 point 035 MG DIANE 35 TAB , IMIPRAMINE 25 MG TAB , HYDROXYUREA 500 MG CAP , CYCLOSPORIN 100 MG TAB , CLOBAZAM 5 MG TAB , PROPRANOLOL 20 MG TAB , ACEBROPHYLLINE 100 MG TAB , FLUOXETINE 20MG TAB , MODAFI0 100 MG TAB , DARIFENACIN 7 point 5 MG TAB , LAMOTRIGINE 25 MG TAB , CLONAZEPAM 0 point 25 MG TAB , QUETIAPINE 25 MG TAB , IBANDRONIC ACID 150 MG TAB , CLOFAZIMINE 100 MG CAP , CLOMIPRAMINE 25 MG TAB , DANAZOL 100 MG TAB , TACROLIMUS 1 MG TAB , DIVALPROEX 500 MG TAB , CHLORTHALIDONE 12 point 5 MG TAB , DIVALPROEX 250 MG TAB , OXCARBAZEPINE 300 MG TAB , METHYLPREDNISOLONE 4 MG TAB , PIRACETAM 400 MG TAB , BUPROPION 150 MG TAB , ESOMEPRAZOLE 40 MG TAB , EPLERENONE 25 MG TAB , ETORICOXCIB 120 MG TAB , FLUNARIZINE 10 MG TAB , RISPERIDONE 1 MG TAB , PROCHLOROPERAZINE 5 MG TAB , PENTOXIFYLLINE 400 MG TAB , SACUBITRIL 97 MG plus VALSARTAN 103 MG TAB
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
Referenced Document
Referenced Document
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 22-01-2025 13:24:55 | |
| 2 | ********** Under PMA | - | 22-01-2025 13:37:12 | |
| 3 | ********** Under PMA | - | 20-01-2025 14:12:53 | |
| 4 | ********** Under PMA | - | 22-01-2025 13:55:33 | |
| 5 | ********** Under PMA | - | 22-01-2025 00:33:35 | |
| 6 | ********** Under PMA | - | 21-01-2025 15:01:58 | |
| 7 | ********** Under PMA | - | 11-01-2025 17:10:24 | |
| 8 | ********** Under PMA | - | 21-01-2025 19:06:34 | |
| 9 | ********** Under PMA | - | 22-01-2025 12:43:37 | |
| 10 | ********** Under PMA | - | 21-01-2025 19:23:39 | |
| 11 | ********** Under PMA | - | 04-01-2025 17:45:32 | |
| 12 | ********** Under PMA | - | 21-01-2025 16:24:00 | |
| 13 | ********** Under PMA | - | 06-01-2025 23:15:22 | |
| 14 | ********** Under PMA | - | 21-01-2025 11:30:35 | |
| 15 | ********** Under PMA | - | 17-01-2025 19:47:18 | |
| 16 | ********** Under PMA | - | 18-01-2025 14:02:12 | |
| 17 | ********** Under PMA | - | 21-01-2025 21:11:10 | |
| 18 | ********** Under PMA | - | 22-01-2025 13:48:55 | |
| 19 | ********** Under PMA | - | 16-01-2025 13:44:48 | |
| 20 | ********** Under PMA | - | 22-01-2025 13:06:17 | |
| 21 | ********** Under PMA | - | 16-01-2025 19:17:56 | |
| 22 | ********** Under PMA | - | 22-01-2025 13:43:46 | |
| 23 | ********** Under PMA | - | 22-01-2025 13:30:16 |
Key insights about MADHYA PRADESH tender market
The eligibility requirements include being a registered entity that can demonstrate relevant prior experience in supplying pharmaceutical goods. Bidder turnover documentation must also be provided. For those seeking exemptions from the experience or turnover criteria, appropriate supporting documentation is necessary.
The required certificates include OEM (Original Equipment Manufacturer) authorization and compliance documentation that affirms the quality and safety of the pharmaceutical products being offered.
To register for participation, prospective bidders must follow the guidelines provided on the procurement platform. Ensure to complete all necessary forms and provide requested documentation to validate your eligibility.
All documents must be submitted in standard formats as specified in the tender invitation, typically in PDF or officially prescribed formats ensuring legibility and completeness for evaluation.
Products must comply with the technical specifications laid out in the tender, ensuring they meet quality standards necessary for healthcare provisions as defined by the Department of Military Affairs.
Bidders must demonstrate compliance with recognized quality standards for pharmaceuticals, including any local regulations or guidelines pertinent to the Ministry of Defence.
Yes, all products must meet the compliance requirements set by applicable health and safety regulations, ensuring they are safe for use and effective as intended.
Bidder products may be subjected to rigorous testing criteria set forth by authorities to ascertain their quality and efficacy, as well as adherence to technical specifications.
The Earnest Money Deposit (EMD) required for participation in this tender is INR 4,200. This deposit must be submitted alongside the tender documents to ensure commitment to the bidding process.
Yes, performance security may be required to ensure contractual obligations are met following the award of the tender. Details regarding this will be outlined in the official tender documents.
Payment terms will be established based on the agreed contract conditions post-award. Bidders are expected to comply with any specified timings or methods for payment processing.
Price evaluation considerations will focus on the overall value offered while ensuring compliance with tender specifications. Competitive pricing that aligns with quality expectations will be prioritized.
Documents must be submitted through the designated online procurement platform, ensuring adherence to submission timelines and correct documentation processes.
Notification of results will typically be communicated through the procurement platform, concluding the evaluation process as outlined in the initial tender submission guidelines.
Micro, Small, and Medium Enterprises (MSEs) may receive special consideration designed to promote their participation in government procurement processes, including potential relaxation of certain eligibility criteria.
Yes, there are provisions that can facilitate the participation of startups, promoting innovation and competition in the procurement processes.
Bidders are encouraged to align with the 'Make in India' policies, which promote local manufacturing and sourcing of goods, thus fostering economic growth and self-reliance.
Bidders must adhere to stipulations regarding local content and procurement rules, which may impact their bid eligibility and evaluation based on the level of local sourcing and manufacturing incorporated in their offerings.
Sign up now to access all documents
Main Document
Referenced Document
Referenced Document